Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients

Anticancer Research

Volumn 21, Issue 1 B, 2001, Pages 585-588

  Mandala M ^a   Moro, C ^a   Ferretti, G ^a   Calabro, M G ^a   Nole F ^a   Rocca, A ^a   Munzone, E ^a   Castro, A ^a   Curigliano, G ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

GH; IGF I; Tamoxifen

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOMEDIN C; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE BLOOD LEVEL; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DRUG EVALUATION; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, HORMONE-DEPENDENT; POSTMENOPAUSE; PROGESTERONE; TAMOXIFEN; TREATMENT OUTCOME;

EID: 0035056441     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Tamoxifen in the treatment of breast cancer
2. Tamoxifen inhibits prolactin signal transduction in ER-NOG-8 mammary epithelial cells
3. Alternative mechanism of action of antiestrogens
4. High, affinity antiestrogen binding site distinct from the estrogen receptor
5. Inhibition of protein Kinase C by tamoxifen
6. Insulin-like growth factors and their binding proteins
7. Secretion of an insulin-like growth factor-1-related protein by human breast cancer cells
8. Somatomedin-C receptors and growth effects in human breast cells mantained in long-term tissue culture
9. Insulin-like growth factor receptor expression and function in human breast cancer
10. Plasma insulin-like growth factor-I (IGF-I) concentration in human breast cancer
11. Growth hormone regulates the abundance of IGF-I mRNA in adult rat liver
12. Tamoxifen attenuates pulsatile growth hormone secretion: Mediation in part by somatostatin
13. Direct effects of tamoxifen on growth hormone secretion by pituitary cells in vitro
14. Influence of tamoxifen on plasma levels of insulin-like growth factor-I and insulin-like growth factor binding protein I in breast cancer patients
15. Effect of tamoxifen on serum insulin-like growth factor-I levels of stage I breast cancer patients
16. Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer
17. Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I(IGF-I) in healthy women
18. In vivo inhibition of insulin-like growth factor-I gene expression by tamoxifen
19. Growth hormone and somatomedin C during postmenopausal replacement therapy with oestrogen alone and in combination with antiestrogen
20. Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer